Section R66-35-5 - Label Requirements(1) The label of a cannabinoid product shall contain the following information, legibly displayed: (a) product name or common name, on the front of the label;(b) brand name, on the front of the label;(c) the size of the container or net count of individual items, on the front of the label;(e) the suggested use of the product, including serving size if the product is intended for consumption;(f) list of ingredients, including: (i) the amount of any advertised cannabinoid listed as present on the COA;(ii) the amount of any primary cannabinoid listed as present on the COA; and(iii) the amount of any THC or any THC analog listed as present on the COA;(h) manufacturer, packer, or distributor name and address; and(2) A fact panel may be included on the product label if it is not identified as a Drug Fact Panel or Nutritional Fact Panel.(3) The label of each product intended for human consumption or intended to be vaporized for inhalation shall include the following text, prominently displayed: "This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."(4) Cannabinoid products containing a cannabinoid other than CBD produced for absorption by humans shall contain the following text, prominently displayed: "Warning - The safety of this product has not been determined."(5) Notwithstanding Subsection R68-26-5(1) a cannabinoid product produced for human use that has a National Drug Code issued shall be labeled in accordance with 21 CFR 201.66.(6) In addition to the requirements of Subsections R68-26-5(1) through R68-26-5(5) a cannabinoid product shall have on the label a scannable barcode, QR code, or web address with an easily located certificate of analysis for the batch identified, containing the information required in Section R68-26-4.(7) Cannabinoid products may not contain medical claims on the label unless the product has been registered with the FDA and is labeled in accordance with Subsection R68-26-5(5).(8) Cannabinoid product labeling shall clearly show that the product contains material derived from industrial hemp and not cannabis or medical cannabis.(9) Cannabinoid product labeling may not: (a) have any likeness bearing resemblance to a cartoon character or fictional character; or(b) appear to imitate a food or other product that is typically marketed toward or appealing to children.(10) A cannabinoid product that is designed to be inhaled shall include a warning on the label regarding the possible health effects of inhaling cannabinoid products.(11) The label of cannabinoid products intended for oral consumption by animals shall include the amount of cannabinoids per serving determined by weight of the animal.(12) The label of cannabinoid products intended for consumption by animal may not: (a) contain any feed claims;(b) be labeled as food; or(c) contain any Food and Drug Administration evaluation statement.(13) A cannabinoid product is considered misbranded if its label is false or misleading in any way.Utah Admin. Code R66-35-5
Adopted by Utah State Bulletin Number 2024-10, effective 5/13/2024